| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $40K | +0.0% |
| R&D Expense | $31K | -96.3% |
| SG&A Expense | $67.5M | +480.7% |
| Operating Income | -$71.1M | -452.7% |
| Interest Expense | $1.6M | — |
| Pre-tax Income | -$464.0M | -4388.0% |
| Income Tax | -$1.3M | — |
| Net Income | -$462.8M | -4379.9% |
| EPS (Basic) | -$9.65 | -1186.7% |
| EPS (Diluted) | -$9.65 | -1186.7% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $20.3M | — |
| Accounts Receivable | $109K | +0.0% |
| Current Assets | $71.9M | — |
| Total Assets | $187.5M | — |
| Current Liabilities | $42.8M | +1790.2% |
| Total Liabilities | $54.2M | +2294.7% |
| Stockholders' Equity | $133.2M | +8726.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$10.4M | -119.4% |
| Investing Cash Flow | -$24.3M | — |
| Financing Cash Flow | $54.9M | +1065.1% |